Literature DB >> 18442855

Cross-sectional and longitudinal factors predicting influenza vaccination in Hong Kong Chinese elderly aged 65 and above.

Joseph T F Lau1, Jean H Kim, Xilin Yang, Hi Yi Tsui.   

Abstract

OBJECTIVES: The study investigated cross-sectional predictors of ever-undergone influenza vaccination (IV) and longitudinal predictors of first-time IV among Chinese elderly in Hong Kong.
METHODS: A random telephone survey interviewed 886 Chinese respondents aged 65 and above and 483 of these 886 respondents (54.5%) completed another follow-up questionnaire.
RESULTS: Of the 483 respondents, 25.1% (or 121) had ever undergone IV at baseline; 13% (47 of 362) were vaccinated for the first time during the follow-up period. The cross-sectional data identified 10 significant variables related to the Health Belief Model (HBM) predicting having ever undergone IV (e.g., perceived efficacy of prevention, side effects, financial difficulty, univariate OR=1.58-68.14 and 0.31-0.47). None of these variables could prospectively predict first-time IV during the follow-up period; the only significant variable was whether the respondent visited social centers during the follow-up period (OR=2.74).
CONCLUSIONS: The 10 studied variables (e.g., perceived efficacy, perceived side effects) were predictive of whether ever undergone IV in the cross-sectional survey. These variables were, however, unable to predict first-time IV in the longitudinal study. Therefore, programs modifying these cross-sectional factors (e.g. change perceptions on efficacy and safety) may not be effective in promoting first-time IV among the elderly. Longitudinal intervention studies are warranted.

Mesh:

Substances:

Year:  2008        PMID: 18442855     DOI: 10.1016/j.jinf.2008.03.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Workplace vaccination and other factors impacting influenza vaccination decision among employees in Israel.

Authors:  Shosh Shahrabani; Uri Benzion
Journal:  Int J Environ Res Public Health       Date:  2010-03-08       Impact factor: 3.390

2.  Deriving behavior model parameters from survey data: self-protective behavior adoption during the 2009-2010 influenza A(H1N1) pandemic.

Authors:  David P Durham; Elizabeth A Casman; Steven M Albert
Journal:  Risk Anal       Date:  2012-05-07       Impact factor: 4.000

3.  Coverage and parental perceptions of influenza vaccination among parents of children aged 6 to 23 months in Hong Kong.

Authors:  Joseph T F Lau; Phoenix K H Mo; Yan Shan Cai; Hi Yi Tsui; Kai Chow Choi
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

Review 4.  Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.

Authors:  Philipp Schmid; Dorothee Rauber; Cornelia Betsch; Gianni Lidolt; Marie-Luisa Denker
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

5.  Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors.

Authors:  George N Okoli; Otto L T Lam; Florentin Racovitan; Viraj K Reddy; Christiaan H Righolt; Christine Neilson; Ayman Chit; Edward Thommes; Ahmed M Abou-Setta; Salaheddin M Mahmud
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 6.  Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review.

Authors:  T Kan; J Zhang
Journal:  Public Health       Date:  2018-02-03       Impact factor: 2.427

7.  Possible role of aerosol transmission in a hospital outbreak of influenza.

Authors:  Bonnie C K Wong; Nelson Lee; Yuguo Li; Paul K S Chan; Hong Qiu; Zhiwen Luo; Raymond W M Lai; Karry L K Ngai; David S C Hui; K W Choi; Ignatius T S Yu
Journal:  Clin Infect Dis       Date:  2010-10-13       Impact factor: 9.079

Review 8.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.